Form 4 for TXG 10x Genomics, Inc.

Accepted 2023-05-25 00:00:00 ET · period of report 2023-05-23 · accession 0001610717-23-000064 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2023-05-25	2023-05-23	TXG	McAnear Justin J.	CFO	S - Sale	$55.06	-1,665	101.9K	-2%	-$91.7K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2023-05-23	S	D	565	$55.06	100,462	D	—	—	(F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
2	Common	Class A Common Stock	2023-05-23	S	D	441	$55.06	101,027	D	—	—	(F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
3	Common	Class A Common Stock	2023-05-23	S	D	465	$55.06	101,468	D	—	—	(F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
4	Common	Class A Common Stock	2023-05-23	S	D	194	$55.07	101,933	D	—	—	(F1) The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units. (F2) Includes 617 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 12, 2023.